Donald B Jump
Overview
Explore the profile of Donald B Jump including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
3423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padiadpu J, Garcia-Jaramillo M, Newman N, Pederson J, Rodrigues R, Li Z, et al.
EMBO Mol Med
. 2023 Oct;
15(11):e18367.
PMID: 37859621
Clinical and preclinical studies established that supplementing diets with ω3 polyunsaturated fatty acids (PUFA) can reduce hepatic dysfunction in nonalcoholic steatohepatitis (NASH) but molecular underpinnings of this action were elusive....
2.
Spooner M, Garcia-Jaramillo M, Apperson K, Lohr C, Jump D
PLoS One
. 2023 Oct;
18(10):e0292432.
PMID: 37819925
Background: Nonalcoholic fatty liver disease (NAFLD) is a global health problem. Identification of factors contributing to the onset and progression of NAFLD have the potential to direct novel strategies to...
3.
Padiadpu J, Spooner M, Li Z, Newman N, Lohr C, Apperson K, et al.
Front Nutr
. 2023 Aug;
10:1147602.
PMID: 37609485
Background: Nonalcoholic fatty liver disease (NAFLD) is a global health problem. Identifying early gene indicators contributing to the onset and progression of NAFLD has the potential to develop novel targets...
4.
Spooner M, Jump D
Annu Rev Nutr
. 2023 May;
43:199-223.
PMID: 37207355
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic fatty liver disease worldwide, particularly in obese and type 2 diabetic individuals. Currently, there are no therapies for NAFLD that...
5.
Zhang Y, Bobe G, Miranda C, Lowry M, Hsu V, Lohr C, et al.
Elife
. 2021 Jun;
10.
PMID: 34128467
We previously reported xanthohumol (XN), and its synthetic derivative tetrahydro-XN (TXN), attenuates high-fat diet (HFD)-induced obesity and metabolic syndrome in C57Bl/6J mice. The objective of the current study was to...
6.
Le D, Garcia-Jaramillo M, Bobe G, Magana A, Vaswani A, Minnier J, et al.
Front Cardiovasc Med
. 2021 May;
8:645786.
PMID: 33969011
While oxylipins have been linked to coronary artery disease (CAD), little is known about their diagnostic and prognostic potential. We tested whether plasma concentration of specific oxylipins may discriminate among...
7.
Rodrigues R, Gurung M, Li Z, Garcia-Jaramillo M, Greer R, Gaulke C, et al.
Nat Commun
. 2021 Jan;
12(1):101.
PMID: 33397942
Western diet (WD) is one of the major culprits of metabolic disease including type 2 diabetes (T2D) with gut microbiota playing an important role in modulating effects of the diet....
8.
Brandao A, Cooke R, Schubach K, Rett B, Souza O, Schachtschneider C, et al.
J Anim Sci
. 2020 Aug;
98(8).
PMID: 32790838
This experiment compared the performance and physiological responses of the offspring from cows supplemented with Ca salts of soybean oil (CSSO) or prilled saturated fat (CON) during late gestation. Nonlactating,...
9.
Brandao A, Cooke R, Schubach K, Colombo E, Scatolin G, Rett B, et al.
Transl Anim Sci
. 2020 Jul;
4(2):txaa061.
PMID: 32705056
This experiment compared plasma fatty acid (FA) profile of forage-fed beef cows receiving a molasses-based supplement enriched with Ca salts of soybean oil [CSSO; 24.7% of dry matter (DM)] via...
10.
Gurung M, Li Z, You H, Rodrigues R, Jump D, Morgun A, et al.
EBioMedicine
. 2020 Jan;
51:102590.
PMID: 31901868
A substantial body of literature has provided evidence for the role of gut microbiota in metabolic diseases including type 2 diabetes. However, reports vary regarding the association of particular taxonomic...